KNSA · Kiniksa Pharmaceuticals International, plc · Investor Relations
$93.90
+0.36 (+0.38%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$7.38B
Shares
78.57M
Volume · Nov 20
545.23K
Avg daily vol (3M)
658.72K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-16 | Jefferies Global Healthcare Conference | Conference |
| 2026-10-27 | Kiniksa Pharmaceuticals Third Quarter 2026 Earnings Conference Call | Earnings call |
| 2026-10-27 | Corporate Presentation – October 2026 | Presentation |
| 2026-09-09 | Wells Fargo 21st Annual Healthcare Conference | Conference |
| 2026-08-12 | Canaccord Genuity 46th Annual Growth Conference | Conference |
| 2026-07-28 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-07-28 | Corporate Presentation – July 2026 | Presentation |
| 2026-06-09 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-03 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-04-28 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-02-24 | Earnings conference call (announced in 8-K) | Earnings call |
Source: https://investors.kiniksa.com/
Key facts
CIK
1730430
CUSIP
G52694109
13F (30d)
280 filings
272 filers
Visit website
Investor relations